Gilead Sciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $24.90B | $19.33B | $9.99B |
| FY2025 | $22.13B | $22.70B | $7.56B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $24.90B | $19.33B | $9.99B |
| FY2025 | $22.13B | $22.70B | $7.56B |